info@synchemia.com | sales@synchemia.com 
9766925136 
Gliclazide EP Impurity B
_1.png)
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Gliclazide is used to treat type 2 diabetes. It's a medicine known as a sulfonylurea. Sulfonylureas increase the amount of insulin your pancreas makes. This lowers your blood sugar.N-Nitroso Gliclazide EP Impurity B is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Gliclazide EP Impurity B chemically represented as 2-Nitroso octahydrocyclopenta[c]pyrrole. Synchemia is the leading manufacturing and exporter of N-Nitroso Gliclazide EP Impurity B.We supply N-Nitroso Gliclazide EP Impurity B with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0143092 |
| CAS No | NA |
| Mol.F. | C16H15ClN4O4S |
| Mol.Wt. | 394.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143093 |
| CAS No | NA |
| Mol.F. | C16H15ClN4O4S |
| Mol.Wt. | 394.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143094 |
| CAS No | NA |
| Mol.F. | C15H13ClN4O4S |
| Mol.Wt. | 380.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143095 |
| CAS No | NA |
| Mol.F. | C14H13ClN4O4S |
| Mol.Wt. | 368.79 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143096 |
| CAS No | NA |
| Mol.F. | C13H17ClN2O6S |
| Mol.Wt. | 364.80 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143097 |
| CAS No | NA |
| Mol.F. | C14H19ClN2O6S |
| Mol.Wt. | 378.82 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143098 |
| CAS No | NA |
| Mol.F. | C15H24N2O4 |
| Mol.Wt. | 296.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143099 |
| CAS No | NA |
| Mol.F. | C18H30N2O6 |
| Mol.Wt. | 370.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143100 |
| CAS No | NA |
| Mol.F. | C12H18N2O3 |
| Mol.Wt. | 238.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143101 |
| CAS No | NA |
| Mol.F. | C14H22N2O4 |
| Mol.Wt. | 282.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143102 |
| CAS No | NA |
| Mol.F. | C15H22N2O5 |
| Mol.Wt. | 310.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143103 |
| CAS No | NA |
| Mol.F. | C9H21N3O2 |
| Mol.Wt. | 203.29 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143104 |
| CAS No | NA |
| Mol.F. | C6H14N2O3 |
| Mol.Wt. | 162.19 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143105 |
| CAS No | NA |
| Mol.F. | C16H24N2O5 |
| Mol.Wt. | 324.38 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143106 |
| CAS No | NA |
| Mol.F. | C15H22N2O5 |
| Mol.Wt. | 310.35 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143107 |
| CAS No | NA |
| Mol.F. | C14H19N2O5 |
| Mol.Wt. | 295.32 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
